(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 137.73%6.88B | ---- | -50.62%2.9B | ---- | -38.61%5.86B | ---- | 92.53%9.55B | ---- | -13.26%4.96B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -123.49%-313.87M | ---- | -17.08%-140.44M | ---- | -107.18%-119.95M | ---- | -23.12%-57.9M | ---- | 47.32%-47.02M |
Investment loss (gain) | ---- | -581.74%-111.12M | ---- | --23.07M | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | 110.34%5.64M | ---- | 11.22%-54.57M | ---- | ---61.47M |
Impairment and provisions: | ---- | -29.24%825.98M | ---- | 127.15%1.17B | ---- | 28.42%513.88M | ---- | -64.98%400.15M | ---- | 136.48%1.14B |
-Impairment of property, plant and equipment (reversal) | ---- | 459.12%7.63M | ---- | -85.62%1.37M | ---- | 300.89%9.49M | ---- | -96.05%2.37M | ---- | --59.91M |
-Impairmen of inventory (reversal) | ---- | 29.76%808.09M | ---- | 78.74%622.73M | ---- | 35.70%348.4M | ---- | 0.50%256.75M | ---- | 42.21%255.47M |
-Impairment of trade receivables (reversal) | ---- | -98.11%4.22M | ---- | -15.69%223.58M | ---- | 61.80%265.2M | ---- | -80.06%163.9M | ---- | --821.85M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13.61M | ---- | ---- |
-Other impairments and provisions | ---- | -98.11%6.04M | ---- | 392.63%319.6M | ---- | -199.35%-109.22M | ---- | -783.09%-36.48M | ---- | -98.24%5.34M |
Revaluation surplus: | ---- | -83.16%33.65M | ---- | 884.71%199.82M | ---- | -204.77%-25.46M | ---- | 232.89%24.3M | ---- | -180.71%-18.29M |
-Fair value of investment properties (increase) | ---- | -99.56%114K | ---- | 1,244.86%25.85M | ---- | -126.38%-2.26M | ---- | 150.45%8.56M | ---- | -426.86%-16.97M |
-Other fair value changes | ---- | -80.72%33.53M | ---- | 849.66%173.97M | ---- | -247.41%-23.21M | ---- | 1,293.56%15.74M | ---- | -105.10%-1.32M |
Asset sale loss (gain): | ---- | 62.76%-152.28M | ---- | 36.13%-408.88M | ---- | -112.27%-640.14M | ---- | -55.97%-301.56M | ---- | 9.73%-193.35M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 11.40%-310.98M | ---- | -9,989.05%-351M | ---- | ---3.48M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -951.64%-14.53M | ---- | 109.97%1.71M | ---- | -588.57%-17.11M | ---- | 150.83%3.5M | ---- | -76.89%-6.89M |
-Loss (gain) from selling other assets | ---- | -38.29%-137.75M | ---- | 63.38%-99.61M | ---- | 9.80%-272.03M | ---- | -61.74%-301.58M | ---- | 11.34%-186.46M |
Depreciation and amortization: | ---- | 5.56%1.57B | ---- | -1.97%1.49B | ---- | -9.91%1.52B | ---- | -3.02%1.69B | ---- | 47.32%1.74B |
-Amortization of intangible assets | ---- | -10.30%65.53M | ---- | 0.88%73.05M | ---- | 17.66%72.42M | ---- | -14.81%61.55M | ---- | --72.25M |
Financial expense | ---- | 206.64%29.41M | ---- | -15.79%9.59M | ---- | -64.83%11.39M | ---- | -77.08%32.39M | ---- | -0.87%141.29M |
Exchange Loss (gain) | ---- | 24.74%-96.66M | ---- | -290.74%-128.44M | ---- | -56.59%67.34M | ---- | 643.55%155.1M | ---- | 46.36%-28.54M |
Special items | ---- | -18.98%-34.81M | ---- | 51.70%-29.26M | ---- | 63.12%-60.57M | ---- | -82.29%-164.22M | ---- | -52.27%-90.09M |
Operating profit before the change of operating capital | ---- | 70.07%8.64B | ---- | -28.83%5.08B | ---- | -36.70%7.13B | ---- | 49.39%11.27B | ---- | 6.94%7.54B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -128.01%-644.43M | ---- | -38.15%2.3B | ---- | 133.31%3.72B | ---- | -751.90%-11.17B | ---- | 16.36%1.71B |
Accounts receivable (increase)decrease | ---- | -156.43%-3.51B | ---- | 379.33%6.23B | ---- | 76.81%-2.23B | ---- | -657.92%-9.61B | ---- | 39.87%-1.27B |
Accounts payable increase (decrease) | ---- | 728.86%11.35B | ---- | 85.20%-1.8B | ---- | -135.12%-12.19B | ---- | 954.58%34.72B | ---- | 473.92%3.29B |
prepayments (increase)decrease | ---- | -591.90%-4.27B | ---- | 255.81%868.35M | ---- | 87.87%-557.3M | ---- | -330.38%-4.59B | ---- | ---1.07B |
Special items for working capital changes | ---- | 183.01%1.02B | ---- | -135.94%-1.23B | ---- | 411.50%3.43B | ---- | 413.92%670.03M | ---- | 207.04%130.38M |
Cash from business operations | 64.27%5.85B | 9.96%12.58B | 117.65%3.56B | 1,740.65%11.44B | -20.59%1.64B | -103.27%-697.06M | -85.60%2.06B | 105.79%21.29B | 176.77%14.31B | 90.99%10.34B |
Other taxs | 11.34%-444.08M | -127.77%-1.19B | -572.86%-500.86M | 79.20%-520.81M | 95.88%-74.44M | -41.82%-2.5B | -121.86%-1.81B | -44.63%-1.77B | -3.03%-815.12M | -17.06%-1.22B |
Interest paid - operating | -73.26%-68.96M | -35.09%-21.25M | -50,278.48%-39.8M | -53.13%-15.73M | 97.21%-79K | 67.18%-10.27M | 86.55%-2.83M | 78.46%-31.3M | 80.44%-21.05M | -1.96%-145.29M |
Net cash from operations | 76.69%5.34B | 4.30%11.37B | 93.41%3.02B | 439.47%10.9B | 526.89%1.56B | -116.47%-3.21B | -98.15%249.09M | 117.09%19.49B | 215.43%13.47B | 112.21%8.98B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -75.20%34.51M | 50.60%207.51M | 158.89%139.15M | -0.55%137.79M | -28.84%53.75M | 122.58%138.54M | 20.10%75.54M | 22.96%62.24M | 2.32%62.9M | -42.52%50.62M |
Loan receivable (increase) decrease | ---51.1M | ---210.9M | ---- | ---- | ---- | ---75M | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | -235.64%-3.39B | ---- | ---1.01B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | -99.47%3.12M | 982.29%117.71M | 7,244.89%590.9M | -58.32%10.88M | -50.72%8.05M | -13.21%26.1M | -40.04%16.32M | -54.60%30.07M | 41.27%27.23M | 228.20%66.23M |
Purchase of fixed assets | 35.59%-830.75M | -75.55%-2.55B | -23.96%-1.29B | 42.33%-1.45B | 37.85%-1.04B | -142.60%-2.52B | -1,659.73%-1.67B | -16.82%-1.04B | 18.18%-95.15M | 34.85%-888.04M |
Selling intangible assets | ---- | ---- | ---- | --9.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | -27.66%-2.45M | 77.82%-11.77M | 90.75%-1.92M | -2.07%-53.09M | 65.92%-20.72M | 91.52%-52.02M | -115.34%-60.78M | -1,421.29%-613.75M | 56.52%-28.23M | 0.18%-40.34M |
Sale of subsidiaries | --561.21M | 181.25%593.13M | ---- | -49.79%210.89M | 880.93%260.57M | 8,515.24%419.99M | 443.79%26.56M | --4.88M | --4.89M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | -116.40%-581.93M | -280.04%-76.01M | 77.14%-268.91M | ---20M | -1,574.67%-1.18B | ---- | ---70.24M |
Recovery of cash from investments | -56.56%17.3B | 76.79%80.51B | 441.97%39.83B | 62.73%45.54B | -60.34%7.35B | -37.21%27.99B | 19.77%18.53B | 27.46%44.58B | 0.48%15.47B | 150.91%34.97B |
Cash on investment | 59.98%-18.17B | -43.57%-89.74B | -264.49%-45.41B | -142.39%-62.51B | 35.75%-12.46B | 46.10%-25.79B | 5.87%-19.39B | -39.68%-47.84B | -19.42%-20.6B | -192.74%-34.25B |
Other items in the investment business | 303.70%16.04M | -66.10%21.87M | -91.95%3.97M | -29.82%64.5M | -35.95%49.32M | -0.03%91.92M | 342.82%76.99M | 75.04%91.94M | -47.09%17.39M | 66.94%52.53M |
Net cash from investment operations | 36.62%-4.53B | 40.60%-11.06B | -21.68%-7.15B | -50,654.15%-18.62B | -142.74%-5.88B | 99.38%-36.68M | 52.90%-2.42B | -5,519.34%-5.9B | -167.81%-5.14B | -110.73%-105.05M |
Net cash before financing | 119.49%804.89M | 104.01%309.16M | 4.28%-4.13B | -137.65%-7.72B | -98.67%-4.31B | -123.90%-3.25B | -126.05%-2.17B | 53.14%13.59B | 254.27%8.34B | 70.33%8.87B |
Cash flow from financing activities | ||||||||||
New borrowing | 23.61%326.15M | --604.97M | --263.86M | ---- | ---- | ---- | ---- | --16M | ---- | ---- |
Refund | ---150.21M | ---195.15M | ---- | ---- | ---- | 41.17%-411.84M | 41.17%-411.84M | 81.01%-700M | 83.54%-700M | 0.11%-3.69B |
Interest paid - financing | -18.33%-1.55M | -2,127.90%-8.07M | ---1.31M | ---362K | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid - financing | -456.36%-259.92M | 50.31%-858.95M | 72.95%-46.72M | 35.81%-1.73B | 38.24%-172.71M | -126.71%-2.69B | -49.21%-279.62M | 38.15%-1.19B | -67.60%-187.4M | -6.86%-1.92B |
Absorb investment income | ---- | -83.33%2M | --2M | -99.78%12M | ---- | --5.53B | --5.53B | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---75.11M | ---63.29M | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -4,651.97%-342.33M | 76.15%-9.48M | 12.04%-7.2M | 91.01%-39.76M | -22.86%-8.19M | 68.76%-442.2M | 99.52%-6.67M | -343.22%-1.42B | -354.22%-1.39B | ---319.4M |
Net cash from financing operations | -304.53%-429.36M | 74.34%-470.96M | 185.26%209.93M | -193.74%-1.84B | -105.12%-246.23M | 159.19%1.96B | 306.93%4.81B | 44.43%-3.31B | 40.21%-2.32B | -139.37%-5.95B |
Effect of rate | 10.40%96.66M | -24.74%96.66M | -44.46%87.56M | 290.74%128.44M | 615.65%157.65M | 56.59%-67.34M | -244.47%-30.57M | -643.55%-155.1M | 83.01%21.16M | -46.36%28.54M |
Net Cash | 109.58%375.54M | 98.31%-161.8M | 14.05%-3.92B | -640.97%-9.55B | -273.15%-4.56B | -112.54%-1.29B | -56.20%2.63B | 252.04%10.28B | 492.70%6.01B | 7.26%2.92B |
Begining period cash | -0.43%15.25B | -38.09%15.32B | -37.97%15.32B | -5.02%24.74B | -5.21%24.69B | 63.59%26.05B | 63.59%26.05B | 22.73%15.92B | 22.73%15.92B | 31.86%12.97B |
Cash at the end | 36.91%15.72B | -0.43%15.25B | -43.40%11.48B | -37.97%15.32B | -29.19%20.29B | -5.21%24.69B | 30.49%28.65B | 63.59%26.05B | 91.69%21.96B | 26.22%15.92B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data